Clinical Trials Directory

Trials / Completed

CompletedNCT01788319

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.

Conditions

Interventions

TypeNameDescription
PROCEDURElasertrabeculoplasty

Timeline

Start date
2013-02-01
Primary completion
2014-12-01
Completion
2015-06-01
First posted
2013-02-11
Last updated
2015-06-23

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01788319. Inclusion in this directory is not an endorsement.